N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE ABNORMAL

N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE ABNORMAL was reported 78 times

These drug classes are most commonly taken by patients reporting N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE ABNORMAL:

# Drug Count
0 Aldosterone Antagonist [EPC] 46
1 Factor Xa Inhibitor [EPC] 35
2 Angiotensin 2 Receptor Blocker [EPC] 30
3 HMG-CoA Reductase Inhibitor [EPC] 29
4 Loop Diuretic [EPC] 19
5 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 17
6 alpha-Adrenergic Blocker [EPC] 17
7 beta-Adrenergic Blocker [EPC] 17
8 Angiotensin Converting Enzyme Inhibitor [EPC] 12
9 5-alpha Reductase Inhibitor [EPC] 9
10 Endothelin Receptor Antagonist [EPC] 9
11 Xanthine Oxidase Inhibitor [EPC] 9
12 Phosphodiesterase 5 Inhibitor [EPC] 8
13 Osmotic Laxative [EPC] 6
14 Nonsteroidal Anti-inflammatory Drug [EPC] 5
15 P2Y12 Platelet Inhibitor [EPC] 5
16 Platelet Aggregation Inhibitor [EPC] 4
17 Potassium Salt [EPC] 4
18 Prostacyclin Receptor Agonist [EPC] 4
19 Prostacycline Vasodilator [EPC] 3
20 Benzodiazepine [EPC] 2
21 Cardiac Glycoside [EPC] 2
22 Human Immunoglobulin G [EPC] 2
23 Programmed Death Receptor-1 Blocking Antibody [EPC] 2
24 Proton Pump Inhibitor [EPC] 2
25 Androgen [EPC] 1
26 Atypical Antipsychotic [EPC] 1
27 CD20-directed Cytolytic Antibody [EPC] 1
28 Calcium Channel Blocker [EPC] 1
29 Dietary Cholesterol Absorption Inhibitor [EPC] 1
30 Dihydropyridine Calcium Channel Blocker [EPC] 1
31 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
32 Ergot Derivative [EPC] 1
33 GLP-1 Receptor Agonist [EPC] 1
34 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
35 Microtubule Inhibitor [EPC] 1
36 Nitrate Vasodilator [EPC] 1
37 Nucleoside Metabolic Inhibitor [EPC] 1
38 Platinum-based Drug [EPC] 1
39 Recombinant Human Growth Hormone [EPC] 1
40 Soluble Guanylate Cyclase Stimulator [EPC] 1
41 Sulfonylurea [EPC] 1
42 Thiazide-like Diuretic [EPC] 1